Udenyca (Biosimilar to Neulasta) Now Approved Page

This banner ad showed up on a page with a news article on nytimes.com. This tells us that this was likely a retargeting ad after visiting an HCP website. In total, there’re 6 frames before ISI starts to auto-scroll, however, the primary message—the first biologic for atopic dermatitis—is part of the first and last frames.
Screenshot taken on September 6, 2017
Humira utilized the rich-media (expandable) banner ad format to connect the unbranded ad to the branded one. The latter comes in after a roll-over, and takes advantage of a larger real estate. Note: we tested this ad on a mobile version of MedPageToday.com (on an iPhone), and roll-over and click did not work.